Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program (Q6930892)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 8092374
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program |
scientific article; zbMATH DE number 8092374 |
Statements
Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program (English)
0 references
12 September 2025
0 references
fitting prior
0 references
interim analysis margin
0 references
meta-survival data
0 references
partial borrowing power prior
0 references
sampling prior
0 references
trial success margin
0 references
0 references
